We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 25

Federal Court confirms "key-hole arrangement" patent lacks inventive step

  • Davies Collison Cave
  • -
  • Australia, Canada
  • -
  • February 24 2014

Justice Robertson of the Federal Court of Australia has recently dismissed an appeal against the Commissioner of Patent's finding that key claims of a

Generic EVISTA kept out of market pending determination of patent infringement claims

  • Davies Collison Cave
  • -
  • Australia
  • -
  • December 5 2013

The Australian Federal Court has recently made orders preventing generic pharmaceutical company, Generic Health, from promoting and selling generic

Federal Court finds that isolated DNA is patentable subject matter in Australia

  • Davies Collison Cave
  • -
  • Australia
  • -
  • February 15 2013

In a much anticipated judgment, on 15 February 2013, the Federal Court of Australia has confirmed that isolated nucleic acid (including isolated DNA

Google not responsible for misleading and deceptive adword advertisements: High Court

  • Davies Collison Cave
  • -
  • Australia
  • -
  • February 6 2013

On 6 February 2013, in a much anticipated judgment, the High Court of Australia unanimously allowed Google's appeal from a decision of the Full Court

Full Federal Court agrees that copyright subsists in original printer cartridge chart

  • Davies Collison Cave
  • -
  • Australia
  • -
  • January 30 2013

In a continuation of a battle between two printer cartridge resellers, the Full Federal Court has affirmed the legal principles pronounced by the

Hospira ordered to withdraw PBS application pending determination of Novartis' Patent infringement claims

  • Davies Collison Cave
  • -
  • Australia
  • -
  • November 14 2012

The Federal Court has recently made orders restraining Hospira from promoting, supplying and obtaining PBS listing of products containing zoledronic acid until its final determination of Novartis’ allegations of patent infringement and Hospira’s cross-claims for invalidity

Merck granted interlocutory relief to stop the alleged infringement of Nasonex patent

  • Davies Collison Cave
  • -
  • Australia
  • -
  • September 11 2012

Justice Jagot of the Federal Court has granted an interlocutory injunction prohibiting the promotion and sale of Apotex's generic versions of Merck's anti-allergic nasal spray, Nasonex

Apotex appeal fails: no implied license over Sanofi's copyright in leflunomide product information

  • Davies Collison Cave
  • -
  • Australia
  • -
  • August 27 2012

The Full Court of the Federal Court of Australia has recently confirmed that Apotex did not have an implied licence to copy the Product Information (PI) for trade rival Sanofi's anti-arthritis drug, Arava (active ingredient leflunomide) for the purposes of obtaining TGA approval of Apotex's generic leflunomide products

Mesoblast not allowed to appeal "Revasc" trade mark decision

  • Davies Collison Cave
  • -
  • Australia
  • -
  • June 5 2012

The Federal Court has recently refused Mesoblast's application for leave to appeal against Justice Jessup's decision to allow, on discretionary grounds, UCP Gen Pharma's "Revasc" pharmaceutical trade mark to remain on the Register of Trade Marks, despite Mesoblast Inc's, opposition, and the fact that the mark had not been used in Australia during the statutory three year "non use" period

Astrazeneca successfully protects Crestor patents against generic attack in the Australian pharmaceutical market

  • Davies Collison Cave
  • -
  • Australia
  • -
  • May 18 2012

Three Justices of the Federal Court of Australia have now on three separate occasions restrained Apotex's proposed launch of generic versions of Astra's cholesterol reducing statin, "Crestor" in Australia